Neurodegenerative diseases present some of the greatest challenges in medicine due to their complexity, heterogeneity, and the limited availability of reliable biomarkers and treatments. Join us for the launch of Olink’s new innovative biomarker solution for neurodegeneration research—designed to empower scientists across academia and industry with greater precision and confidence.
This powerful new panel enables simultaneous, absolute quantification of both established and emerging key neurodegenerative biomarkers, unlocking new translational insights into disease mechanisms previously beyond reach.
Whether you're investigating disease pathways, developing interventions, or evaluating treatment response, this webinar will introduce an innovative tool to drive your work forward with greater clarity and confidence.
Learn how this comprehensive tool can support you to: